Under the Radar Report looks at three of the best growth stocks that have performed well for subscribers. What we’re looking for is organic growth stocks, which is the Holy Grail for all investors in companies big and small.
The Best Growth Stocks: Volpara Health Technology (VHT)
Volpara Health Technology (VHT) is one of our best growth stocks. This growth stock produces a proprietary technology utilising AI to improve breast cancer screening and has succeeded in accessing the US market. This growth stock sales multiple is very high, but so is its growth outlook. After a share price run subsequent to our spec buy recommendation its market cap is getting big, but we continue to think it is good value relative to its potential and is postioned for growth. To uncover more of the best growth stocks in 2020, join now.
The Best Growth Stocks: Nanosonics (NAN)
Another one of our best growth stocks in 2020 is ultrasound sterilising specialist Nanosonics (NAN). The share price of this company, which is one of our best growth stock reflects the law of large numbers. This growth stock has a market valuation just under $2bn. Unless its total addressable market is much bigger than these other companies, the possibility of it continuing sales growth and maintaining its sales multiple gets exponentially more difficult. We recognise how powerful this growth stocks niche is and we’ve taken risk off the table by realising some gains. The growth paradigm isn’t broken, so we’re letting our profits run. To uncover more of the best growth stocks in 2020, join now.
Download your free report.
Our best performing stocks.
The Best Growth Stocks: Medical Developments (MVP)
Another one of our best growt stocks is the Green Whistle producer Medical Developments (MVP). This is one of our best growth stocks as we have had some success buying and selling this growth stock, but if you were simply going on the growth of 15% you would not be a buyer. So why are we recommending this growth stock? It’s the growth potential that you can’t see that is embedded in its system that has got our attention, having covered the growth stock for a long time.
This is a growth stock that has invested millions in a global distribution network. We admit that the size of the global market for the Penthrox Green Whistle is very difficult to analyse and will only become clear over time. Against this, you have FY19 sales growth in Australian ambulances of 38%, which is the kind of growth potential we’re talking about on a global basis. This growth potential has been delayed, which is why the estimates are subdued, but (another but) this growth stock can surprise on the upside because of its investment in distribution. There are dozens of countries where this growth stock is licenced to sell, where it has not sold anything yet, plus the potential from cracking the US and other markets.
We continue to rate the growth stock a Spec Buy, but it has had phenomenal share price appreciation due in no small part to its entry into the giant Chinese market, announced last month. We’ll be reviewing this growth stock in our next issue. To uncover more of the best growth stocks in 2020, join now.
JOIN TODAY FOR FREE AND ACCESS MORE ASX GROWTH STOCKS!